SAMDaily.us | SNOTE | 65 | Post-Award Limited Sources Justification (LSJ) - Xofluza (Baloxavir Marboxil)

SAMDAILY.US - ISSUE OF OCTOBER 17, 2025 SAM #8726
SPECIAL NOTICE

65 -- Post-Award Limited Sources Justification (LSJ) - Xofluza (Baloxavir Marboxil)

Notice Date: 10/15/2025 6:24:01 AM
Notice Type: Justification
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Contracting Office: ASPR/ORM-SNS Atlanta GA 30341 USA
ZIP Code: 30341
Solicitation Number: 75A50325Q00021
Archive Date: 11/14/2025
Point of Contact: Leatrice Bulls, Kimberly Golden
E-Mail Address: OSContracting@hhs.gov, OSContracting@hhs.gov
(OSContracting@hhs.gov, OSContracting@hhs.gov)
Award Number: GS00F022CA
Award Date: 09/26/2025
Description: Post-Award Limited Sources Justification (LSJ) - Xofluza (Baloxavir Marboxil)
Web Link: SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/4bbf86fb508c44a5a6c6e1b15beefc5e/view)
Place of Performance: Address: Reston, VA, USA; Country: USA
Record: SN07618848-F 20251017/251015230034 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |